MetrioPharm’s MP1032 Awarded EMA Orphan Drug Designation for Duchenne Muscular Dystrophy
The European Medicines Agency acknowledges the potential of the primary compound, MP1032, to address a significant unmet medical need in […]
The European Medicines Agency acknowledges the potential of the primary compound, MP1032, to address a significant unmet medical need in […]